Frank Facchini, Md Fsir Email and Phone Number

• Board Certified Clinician with focus on image guided minimally invasive therapies including interventional oncology, liver pathology, spine intervention, arterial and venous vascular disease.• Director, Interventional Oncology• Fellow of the Society of Interventional Radiology

CMO of a private equity owned $155Minternational biotech firm dedicated to the percutaneous and interventional medical specialties.• Member of senior executive team with direct responsibility in evaluation of clinical, business and corporate strategic intent. Leadership role in due diligence and reverse due diligence of $372M acquisition of Navilyst medical by Angiodynamics. (ANGO)• Focus on business portfolio development and planning process, organic product development and commercial launch, mergers and acquisitions, clinical research and development, process implementation and change.• Spearhead new technology and acquisition assessments.• Establish environment for optimum cross-functional collaboration, recognition, and teamwork both domestically and internationally.• Provide insight and clinical supervision to research and development.• Provide clinical support to the regulatory and compliance group in the interaction with the FDA. Design and supervise clinical and DV studies. Evaluate quality and compliance clinical impact.• Clinically train entire sales and management team as well as support key account management.• Assembled and chair the corporate Medical Advisory Board.